Merck (MRK) Share-based Compensation Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
4.55% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
4.17% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
8.29% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-5.13% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-11.76% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
4.31% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
60.00% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
1.39% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-5.13% |
| Dec 31, 2025 |
9.63% |
| Sep 30, 2025 |
4.62% |
| Jun 30, 2025 |
6.40% |
| Mar 31, 2025 |
10.80% |
| Dec 31, 2024 |
11.98% |
| Sep 30, 2024 |
18.90% |
| Jun 30, 2024 |
20.12% |
| Mar 31, 2024 |
21.38% |
| Dec 31, 2023 |
15.17% |
| Sep 30, 2023 |
17.99% |
| Jun 30, 2023 |
23.36% |
| Mar 31, 2023 |
20.83% |
| Dec 31, 2022 |
21.85% |
| Sep 30, 2022 |
18.80% |
| Jun 30, 2022 |
3.79% |
| Mar 31, 2022 |
8.11% |
| Dec 31, 2021 |
6.25% |
| Sep 30, 2021 |
-7.14% |
| Jun 30, 2021 |
9.09% |
| Mar 31, 2021 |
2.78% |
| Dec 31, 2020 |
36.59% |
| Sep 30, 2020 |
24.75% |
| Jun 30, 2020 |
9.01% |
| Mar 31, 2020 |
16.13% |
| Dec 31, 2019 |
-5.75% |
| Sep 30, 2019 |
10.99% |
| Jun 30, 2019 |
23.33% |
| Mar 31, 2019 |
16.25% |
| Dec 31, 2018 |
8.75% |
| Sep 30, 2018 |
19.74% |
| Jun 30, 2018 |
9.76% |
| Mar 31, 2018 |
8.11% |
| Dec 31, 2017 |
6.67% |
| Sep 30, 2017 |
-1.30% |
| Jun 30, 2017 |
2.50% |
| Mar 31, 2017 |
8.82% |
| Dec 31, 2016 |
-3.85% |
| Sep 30, 2016 |
2.67% |
| Jun 30, 2016 |
-3.61% |
| Mar 31, 2016 |
7.94% |
| Dec 31, 2015 |
13.04% |
| Sep 30, 2015 |
0.00% |
| Jun 30, 2015 |
6.41% |
| Mar 31, 2015 |
12.50% |
| Dec 31, 2014 |
4.55% |
| Sep 30, 2014 |
10.29% |
| Jun 30, 2014 |
4.00% |
| Mar 31, 2014 |
-16.42% |
| Dec 31, 2013 |
-15.38% |
| Sep 30, 2013 |
-22.73% |
| Jun 30, 2013 |
-19.35% |
| Mar 31, 2013 |
-11.84% |
| Dec 31, 2012 |
-4.88% |
| Sep 30, 2012 |
2.33% |
| Jun 30, 2012 |
-13.08% |
| Mar 31, 2012 |
-18.28% |
| Dec 31, 2011 |
-24.77% |
| Sep 30, 2011 |
-31.75% |
| Jun 30, 2011 |
-24.65% |
| Mar 31, 2011 |
-29.55% |
| Dec 31, 2010 |
-18.17% |
| Sep 30, 2010 |
48.76% |
| Jun 30, 2010 |
69.45% |
| Mar 31, 2010 |
16.50% |
